Alx Oncology Holdings (ALXO) EPS (Basic) (2019 - 2026)
Alx Oncology Holdings (ALXO) reported EPS (Basic) of -$0.21 for Q1 2026, up 64.12% on a YoY basis from -$0.13 in Q1 2025, and up 51.92% sequentially from -$0.43 in Q4 2025.
Alx Oncology Holdings (ALXO) EPS (Basic) (2019 - 2026) Analysis & Trends
Alx Oncology Holdings (ALXO) has 8 years of EPS (Basic) data on file, last reported at -$0.21 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 64.12% year-over-year to -$0.21; the trailing twelve-month figure through Mar 2026 stood at -$0.92 (up 63.19% YoY), and the FY2025 full-year result was -$0.01, up 99.55% from the prior year.
- EPS (Basic) advanced to -$0.21 in Q1 2026, from -$0.43 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.21 in Q1 2026 to a low of -$1.24 in Q3 2023.
- A 5-year average of -$0.71 and a median of -$0.75 in 2022 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) sank 109.34% in 2022 and jumped 64.12% in 2026, its largest moves.
- Tracing ALXO's EPS (Basic) over 5 years: stood at -$0.75 in 2022, then sank by 41.08% to -$1.06 in 2023, then jumped by 46.74% to -$0.57 in 2024, then gained by 23.99% to -$0.43 in 2025, then jumped by 51.92% to -$0.21 in 2026.
- Business Quant data shows ALXO's EPS (Basic) at -$0.21 in Q1 2026, -$0.43 in Q4 2025, and -$0.41 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Alx Oncology Holdings | 211.24 Mn | 211.24 Mn | - | -0.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.21 |
| Dec 31, 2025 | -0.43 |
| Sep 30, 2025 | -0.41 |
| Jun 30, 2025 | -0.55 |
| Mar 31, 2025 | -0.58 |
| Dec 31, 2024 | -0.57 |
| Sep 30, 2024 | -0.58 |
| Jun 30, 2024 | -0.81 |
| Mar 31, 2024 | -0.77 |
| Dec 31, 2023 | -1.06 |
| Sep 30, 2023 | -1.24 |
| Jun 30, 2023 | -0.91 |
| Mar 31, 2023 | -0.78 |
| Dec 31, 2022 | -0.75 |
| Sep 30, 2022 | -0.87 |
| Jun 30, 2022 | -0.85 |
| Mar 31, 2022 | -0.63 |
| Dec 31, 2021 | -0.71 |
| Sep 30, 2021 | -0.61 |
| Jun 30, 2021 | -0.40 |